Our present study suggests that Spred2 functions to suppress the growth and progression of cancer in non-invasive bladder cancer through suppressing the ERK pathway, and this regulatory mechanism no longer functions in invasive bladder cancer. Here, SPRED2 is linked to urinary bladder cancer.